ArticleClinicoEconomics and outcomes research : CEOR2013

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden.

Jaro Wex et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.